Veralto Reports Strong Q4 & FY25 Results, Boosts Shareholder Returns, and Guides for 2026 Growth
summarizeSummary
Veralto reported strong Q4 and full-year 2025 financial results, announced a new share repurchase program and an 18% dividend increase, and provided positive guidance for 2026.
check_boxKey Events
-
Strong Q4 and Full Year 2025 Performance
Veralto reported Q4 2025 sales of $1,396 million (+3.8% YoY, +1.6% core sales) and adjusted diluted EPS of $1.04. For the full year 2025, sales reached $5,503 million (+6.0% YoY, +4.7% core sales) with adjusted diluted EPS of $3.90 and over $1 billion in free cash flow.
-
Positive 2026 Financial Guidance
The company anticipates Q1 2026 core sales growth to be flat to low-single digits and full-year 2026 core sales growth in the low-to-mid-single digits. Adjusted diluted EPS is projected to be $0.97 to $1.01 for Q1 2026 and $4.10 to $4.20 for the full year 2026, representing mid-to-high single-digit growth.
-
Strategic Capital Allocation Initiatives
Veralto established a $750 million share repurchase program and announced an 18% increase in its dividend. The company also completed the acquisition of In-Situ in late January, expanding its water analytics portfolio.
auto_awesomeAnalysis
Veralto Corporation delivered strong financial results for both the fourth quarter and full year 2025, exceeding $1 billion in free cash flow for the year. The company also provided a positive outlook for 2026, anticipating continued core sales growth and adjusted earnings per share expansion, albeit with a slight moderation in sales growth compared to 2025. Furthermore, Veralto announced significant capital allocation initiatives, including a substantial share repurchase program and an 18% increase in its dividend, signaling confidence in future performance and a commitment to shareholder returns. The recent acquisition of In-Situ also expands its water analytics portfolio.
At the time of this filing, VLTO was trading at $96.53 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $24.2B. The 52-week trading range was $83.87 to $110.11. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.